Targeting apoptosis in cancer

P Singh, B Lim - Current oncology reports, 2022 - Springer
Abstract Purpose of Review Apoptosis is a major mechanism of cancer cell death. Thus,
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …

The role of TP53 in acute myeloid leukemia: challenges and opportunities

K Barbosa, S Li, PD Adams… - Genes, Chromosomes …, 2019 - Wiley Online Library
The tumor suppressor gene TP53 is one of the most frequently mutated genes in human
cancer. The central role of the TP53 protein in several fundamental processes such as …

Circulating and urinary tumour DNA in urothelial carcinoma—Upper tract, lower tract and metastatic disease

KM Rose, HL Huelster, JJ Meeks, BM Faltas… - Nature Reviews …, 2023 - nature.com
Precision medicine has transformed the way urothelial carcinoma is managed. However,
current practices are limited by the availability of tissue samples for genomic profiling and …

[HTML][HTML] Evolving strategies and application of proteins and peptide therapeutics in cancer treatment

AG Mukherjee, UR Wanjari, AV Gopalakrishnan… - Biomedicine & …, 2023 - Elsevier
Several proteins and peptides have therapeutic potential and can be used for cancer
therapy. By binding to cell surface receptors and other indicators uniquely linked with or …

Molecular approaches to treating pediatric leukemias

M Kuhlen, JH Klusmann, JI Hoell - Frontiers in Pediatrics, 2019 - frontiersin.org
Over the past decades, striking progress has been made in the treatment of pediatric
leukemia, approaching 90% overall survival in children with acute lymphoblastic leukemia …

New challenges in targeting signaling pathways in acute lymphoblastic leukemia by NGS approaches: an update

A Montaño, M Forero-Castro, D Marchena-Mendoza… - Cancers, 2018 - mdpi.com
The identification and study of genetic alterations involved in various signaling pathways
associated with the pathogenesis of acute lymphoblastic leukemia (ALL) and the application …

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax

K Fidyt, A Pastorczak, J Cyran, NT Crump, A Goral… - Oncogene, 2022 - nature.com
The prognosis for B-cell precursor acute lymphoblastic leukemia patients with Mixed-
Lineage Leukemia (MLL) gene rearrangements (MLLr BCP-ALL) is still extremely poor …

p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents

SK Nayak, GL Khatik, R Narang… - Current cancer drug …, 2018 - ingentaconnect.com
Background: Cancer is a major global health problem with high mortality rate. Most of the
clinically used anticancer agents induce apoptosis through genotoxic stress at various …

[HTML][HTML] An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues

T Liu, L Gu, A Mui, Z Wu, N Albadari, W Li, M Zhou - Cancer letters, 2024 - Elsevier
The MDM2 oncogene is amplified and/or overexpressed in various human cancers and
elevated expression of MDM2 protein acts as a survival factor promoting cancer progression …

Schizophrenia risk ZNF804A interacts with its associated proteins to modulate dendritic morphology and synaptic development

F Dong, J Mao, M Chen, J Yoon, Y Mao - Molecular Brain, 2021 - Springer
Schizophrenia (SZ) is a devastating brain disease that affects about 1% of world population.
Among the top genetic associations, zinc finger protein 804A (ZNF804A) gene encodes a …